Previous 10 | Next 10 |
Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the University of Natural Resources and Life Sciences (BOKU) Vienna FREEHOLD, N.J., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCa...
Avalon and research partner, University of Natural Resources and Life Sciences (BOKU), in Vienna, Austria, co-develop a novel technology to efficiently synthesize and study previously difficult to work with drug targets Technology will facilitate drug design for cancer and immune-...
FREEHOLD, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it will be presenting at the Benzinga Healthcare Small Cap Conference, w...
Atossa Therapeutics is clinical-stage biotech whose stock has trended a highly volatile path during the last one-year period. In addition to breast cancer research, where the company has been involved for years, it also focuses on producing nasal drops and inhalation therapy for comba...
HERNDON, Va., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sysorex (OTCQB: SYSX) (“Sysorex” or the “Company”), the preeminent, U.S.-based, publicly traded Ethereum mining and technologies company, today announced that it has elected William B. Stilley, III to the Company...
Gainers: PharmaCyte Biotech (NASDAQ:PMCB) +118%. Virpax Pharmaceuticals (NASDAQ:VRPX) +59%. SGOCO Group (NASDAQ:SGOC) +53%. AzurRx BioPharma (NASDAQ:AZRX) +30%. NRx Pharmaceuticals (NASDAQ:NRXP) +26%. Standard Lithium (NYSE:SLI) +21%. ESSA Pharma (NASDAQ:EPIX) +15%. Agrify (NASDAQ:AGFY) +17%....
PITTSBURGH, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A new collaboration among UPMC Hillman Cancer Center , the University of Pittsburgh and New Jersey-based biotechnology company Avalon GloboCare Corp. (NASDAQ: AVCO) aims to develop new cancer immunotherapy approaches and streamline m...
NEW YORK, NY / ACCESSWIRE / July 20, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Kite Realty Group Trust (NYSE:KRG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties r...
Trial evaluating EphA2-targeted CAR T-cell therapy in recurrent glioblastoma, an urgent and significant unmet medical need with no standard of care treatment option Anti-EphA2 CAR-T therapy appears to be well-tolerated thus far, based on initial safety data from first patient co...
Previously Announced Execution of Definitive Agreement to Acquire SenlangBio SenlangBio Generated Revenue of USD $1.2 Million for the Three Months Ended March 31, 2021 and Projects $5 Million to $7 Million in Revenue for the Full Year 2021 USD $30 Million of Committed Capi...
News, Short Squeeze, Breakout and More Instantly...
Avalon GloboCare Corp. Company Name:
AVCO Stock Symbol:
NASDAQ Market:
Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s New Focus on Laboratory Services and Biotherapeutics FREEHOLD, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon...
Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of $25 million, net income in excess of $10 million and over 600,000 tests completed since inception Cash portion to be financed with a ...
Freehold, New Jersey--(Newsfile Corp. - October 19, 2022) - Avalon GloboCare Corp. (NASDAQ: AVCO) , a leading global developer of innovative cell-based technologies and therapeutics, announced today that David Jin, M.D., Ph.D., President and Chief Executive Officer, and Luisa Ingargiola, Ch...